Skip to main content
PMC home page
Cytotechnology logoLink to Cytotechnology
. 2000 Oct;34(1-2):111–119. doi: 10.1023/A:1008167713696

Comparison of cell growth in T-flasks, in micro hollow fiber bioreactors, and in an industrial scale hollow fiber bioreactor system

Michael J Gramer 1, Douglas M Poeschl 1
PMCID: PMC3449739  PMID: 19003385

Abstract

In this article, cell growth in a novel micro hollow fiberbioreactor was compared to that in a T-flask and theAcuSyst-Maximizer®, a large scale industrial hollowfiber bioreactor system. In T-flasks, there was relativelylittle difference in the growth rates of one murine hybridomacultured in three different media and for three other murinehybridomas cultured in one medium. However, substantialdifferences were seen in the growth rates of cells in themicro bioreactor under these same conditions. These differencecorrelated well with the corresponding rates of initial cellexpansion in the Maximizer. Quantitative prediction of thesteady-state antibody production rate in the Maximizer was moreproblematic. However, conditions which lead to faster initialcell growth and higher viable cell densities in the microbioreactor correlated with better performance of a cell line inthe Maximizer. These results demonstrate that the microbioreactor is more useful than a T-flask for determining optimalconditions for cell growth in a large scale hollow fiberbioreactor system.

Keywords: cell culture, hollow fiber bioreactor, hybridoma, micro bioreactor, optimization, T-flask

Full Text

The Full Text of this article is available as a PDF (150.8 KB).

References

  1. Ala-Uotila S, Marjamaki A, Matikainen M-T, Jalkanen M. Use of a hollow fiber bioreactor for large scale production of α2-adrenoceptors in mammalian cells. J Biotechnol. 1994;37:179–184. doi: 10.1016/0168-1656(94)90009-4. [DOI] [PubMed] [Google Scholar]
  2. Banik GG, Heath CA. High density hybridoma perfusion culture: Limitation vs. inhibition. Appl Biochem Biotechnol. 1996;61:211–229. doi: 10.1007/BF02787797. [DOI] [PubMed] [Google Scholar]
  3. Brotherton JD, Chau PC. Modeling of axial flow hollow fiber cell culture bioreactors. Biotechnol Prog. 1996;12:575–590. [Google Scholar]
  4. Chuppa S, Tsai Y-S, Yoon S, Shakelford S, Rozales C, Bhat R, Tsay G, Matanguihan C, Konstantinov K, Naveh D. Fermentor temperature as a tool for control of high density perfusion cultures of mammalian cells. Biotechnol Bioeng. 1997;55:328–338. doi: 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  5. Gramer MJ, Poeschl DM, Conroy MJ, Hammer BE. Effect of harvesting protocol on performance of a hollow fiber bioreactor. Biotechnol Bioeng. 1999;65:334–340. doi: 10.1002/(sici)1097-0290(19991105)65:3<334::aid-bit11>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  6. Gramer MJ, Poeschl DM. Screening tool for hollow fiber bioreactor process development. Biotechnol Prog. 1998;14:203–209. doi: 10.1021/bp9800081. [DOI] [PubMed] [Google Scholar]
  7. Hirschel MD, Gruenberg ML. In: An automated hollow fiber system for the large scale manufacture of mammalian cell secreted product. Lydersen BK, editor. Macmillan: Large Scale Cell Culture Technology.; 1988. pp. 113–144. [Google Scholar]
  8. Kidwell WR. Filtering out inhibition. Bio/Technology. 1989;7:462–463. [Google Scholar]
  9. Knazek RA, Wu Y-W, Aebersold PM, Rosenberg SA. Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors. J Immunol Methods. 1990;127:29–37. doi: 10.1016/0022-1759(90)90337-u. [DOI] [PubMed] [Google Scholar]
  10. Liu JJ, Chen B-S, Tsai T-F, Wu Y-J, Pang VF, Hseih A, Hsieh JH, Chang TH. Long term and large scale cultivation of human hepatoma Hep G2 cells in hollow fiber bioreactor. Cytotechnology. 1991;5:129–139. doi: 10.1007/BF00365429. [DOI] [PubMed] [Google Scholar]
  11. Ozturk SS, Palsson BO. Growth, metabolic, and antibody production kinetics of hybridoma cell culture. Biotechnol Prog. 1991;7:481–494. doi: 10.1021/bp00012a002. [DOI] [PubMed] [Google Scholar]
  12. Ozturk SS, Riley MR, Palsson BO. Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production. Biotechnol Bioeng. 1992;39:418–431. doi: 10.1002/bit.260390408. [DOI] [PubMed] [Google Scholar]
  13. Palsson BO, Paek S-H, Schwartz RM, Palsson M, Lee G-M, Silver S, Emerson SG. Expansion of human bone marrow progenitor cells in a high density continuous perfusion system. Bio/Technology. 1993;11:368–371. doi: 10.1038/nbt0393-368. [DOI] [PubMed] [Google Scholar]
  14. Patkar AY, Koska J, Taylor DG, Bowen BD, Piret JM. Protein transport in ultrafiltration hollow fiber bioreactors. AIChE J. 1995;41:415–425. [Google Scholar]
  15. Piret JM, Cooney CL. Model of oxygen transport limitations in hollow fiber bioreactors. Biotechnol Bioeng. 1991;37:80–92. doi: 10.1002/bit.260370112. [DOI] [PubMed] [Google Scholar]
  16. Ratner PL, Cleary ML, James E. Production of rapid harvest Moloney murine leukemia virus by continuous cell culture on synthetic capillaries. J Virol. 1978;26:536–539. doi: 10.1128/jvi.26.2.536-539.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richards SM, Garman RD, Keyes L, Kavanagh B, McPherson JM. Prolactin is an antagonist of TGF-β activity and promotes proliferation of murine B cell hybridomas. Cell Immunol. 1998;184:85–91. doi: 10.1006/cimm.1998.1275. [DOI] [PubMed] [Google Scholar]
  18. Schlapfer BS, Scheibler M, Holtorf A-P, Nguyen HV, Pluschke G. Development of optimized transfectoma cell lines for production of chimeric antibodies in hollow fiber cell culture systems. Biotechnol Bioeng. 1995;45:310–319. doi: 10.1002/bit.260450405. [DOI] [PubMed] [Google Scholar]
  19. Stronek DF, Hubel A, Shankar RA, Burger SR, Pan D, McCullough J, Whitley CB. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome. Transfusion. 1999;39:343–350. doi: 10.1046/j.1537-2995.1999.39499235664.x. [DOI] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES